There is a growing recognition in oncology of the importance of maintaining or improving patients’ quality of life (QOL) throughout the disease course. With this goal in mind, many clinical trials in oncology now seek to evaluate QOL end points.
Kimberly Davis, PhD
Advertisement
Articles by Kimberly Davis, PhD
Advertisement
Latest Updated Articles
- Assessing Quality of Life in Research and Clinical Practice
Published: September 3rd 2002 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
2
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
3
H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice
4
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
5
